Appendix Table 1.
Natural Language Processing terminology utilized to examine all anal cytology and histopathology results.
| Disease Grade | NLP Search Term |
|---|---|
| Negative | NEGATIVE FOR INTRAEPITHELIAL |
| NEGATIVE FOR SQUAMOUS INTRAEPITHELIAL LESION | |
| NEGATIVE FOR MALIGNANCY OR INTRAEPITHELIAL LESION | |
| NEGATIVE FOR CONDYLOMA OR MALIGNANCY | |
| NEGATIVE FOR DYSPLASIA | |
| NO EVIDENCE OF INTRAEPITHELIAL LESION | |
| NO EVIDENCE OF DYSPLASIA | |
| NO DEFINITIVE EVIDENCE OF INTRAEPITHELIAL LESION OR MALIGNANCY | |
| NO DEFINITIVE EVIDENCE OF DYSPLASIA | |
| NEGATIVE FOR CHRONIC CHANGES, DYSPLASIA | |
| NO INTRA-EPITHELIAL OR INVASIVE NEOPLASM | |
| NAGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY | |
| Atypical Squamous Cells of Undetermined Significance (ASCUS) | ASCUS |
| ASC-US | |
| ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE | |
| ATYPICAL SQUAMOUS CELLS OF UNDETERINED SIGNIFICANCE | |
| ATYPICAL SQUAMOUS CELLS OF UNDETEREMINED SIGNIFICANCE | |
| Atypical Squamous Cells – Cannot Exclude High-Grade (ASC-H) | ASC-H |
| Low-grade anal intraepithelial neoplasia (LGAIN) | LSIL |
| LGSIL | |
| LOW GRADE | |
| LOW-GRADE | |
| ACIN-I) | |
| ACIN-I | |
| ACIN I) | |
| ACIN I | |
| AIN-I) | |
| AIN-I | |
| AIN I) | |
| AIN I | |
| MILD DYSPLASIA | |
| AIN-1 | |
| High-grade anal intraepithelial neoplasia (HGAIN) | CARCINOMA IN SITU |
| CARCINOMA IN-SITU | |
| IN-SITU SQUAMOUS CARCINOMA | |
| MODERATE DYSPLASIA | |
| SEVERE DYSPLASIA | |
| MODERATE SQUAMOUS DYSPLASIA | |
| SEVERE SQUAMOUS DYSPLASIA | |
| AIN-2 | |
| AIN 2 | |
| AIN2 | |
| AIN 1–2 | |
| ACIN-II | |
| ACIN II | |
| CIN II | |
| CIN-II | |
| AIN II | |
| AIN-II | |
| AIN II | |
| AIN-3 | |
| AIN 3 | |
| AIN3 | |
| (AIN) II | |
| ANAL INTRAEPITHELIAL NEOPLASIA-3 | |
| ANAL INTRAEPITHELIAL NEOPLASIA-II | |
| ANAL INTRAEPITHELIAL NEOPLASIA II | |
| ANAL INTRAEPITHELIAL NEOPLASIA 3 | |
| ANAL INTRAEPITHELIAL NEOPLASIA 2 | |
| HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION | |
| HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION | |
| HSIL Exclude: CANNOT EXCLUDE HSIL CANNOT RULE OUT HSIL |
|
| H.S.I.L | |
| HGSIL Exclude: CANNOT EXCLUDE HGSIL CANNOT RULE OUT HGSIL |
|
| HIGH GRADE Exclude: NO EVIDENCE OF HIGH GRADE NEGATIVE FOR HIGH GRADE NOT EXCLUDE HIGH GRADE NOT EXCLUDE A HIGH GRADE HIGH GRADE CAN NOT HIGH GRADE CANNOT |
|
| HIGH-GRADE Exclude: NO EVIDENCE OF HIGH-GRADE NEGATIVE FOR HIGH-GRADE NOT EXCLUDE HIGH-GRADE NOT EXCLUDE A HIGH-GRADE HIGH-GRADE CAN NOT HIGH-GRADE CANNOT |
|
| Anal Cancer | INVASIVE SQUAMOUS CELL CARCINOMA |
| METASTATIC SQUAMOUS CELL CARCINOMA | |
| INVASIVE MODERATELY DIFFERENCIATED SQUAMOUS CELL CARCINOMA | |
| INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA | |
| POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA | |
| DIFFERENTIATED SQUAMOUS CELL Also contains: CARCINOMA |
|
| MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA | |
| POORLY DIFFERENTIATED CARCINOMA | |
| SQUAMOUS CELL CARCINOMA INVASIVE Also contains: DIFFERENTIATED |
|
| Unsatisfactory | UNSATISFACTORY FOR EVALUATION |
| UNSATISFACTORY FOR INTERPRETATION |